Visionary Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Visionary Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,494	Closed	-$527K	–	298
2018 Q3	$527K	Buy	5,494 +220	+4%	+$21.3K	0.17%	108
2018 Q2	$502K	Buy	5,274 +234	+5%	+$21.5K	0.17%	100
2018 Q1	$425K	Sell	5,040 -21	-0.4%	-$1.92K	0.14%	102
2017 Q4	$430K	Buy	5,061 +2,246	+80%	+$188K	0.12%	105
2017 Q3	$244K	Sell	2,815 -204	-7%	-$16.4K	0.07%	174
2017 Q2	$233K	Buy	+3,019	New	+$214K	0.07%	173

Other funds holding XBI

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Visionary Asset Management's XBI Position: Q4 2018 in Review

Visionary Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 5,494 shares — an estimated $527K sold.

Visionary Asset Management first reported a position in XBI in Q2 2017 and held it in 6 quarters. The position peaked at $527K in Q3 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

Visionary Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
Visionary Asset Management sold 5,494 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $527K.
Visionary Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 6 quarters.
Visionary Asset Management's State Street SPDR S&P Biotech ETF position peaked at $527K in Q3 2018.
427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on Visionary Asset Management's 13F filing for Q4 2018, filed 11 Jan 2019.